---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-020596"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2022-08-03T23:59:59+00:00"
generated_at: "2026-06-24T05:35:59.487199+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Medifast Q2 revenue up 15% to $453.3M, net income down 16.7%; cuts full-year guidance on macro headwinds

## Summary
- Revenue $453.3M (+15% YoY); net income $39.1M (-16.7%); adjusted EPS $3.87 (-2.5%).
- Active earning coaches 68,000 (+14.9%); revenue per coach $6,667 slightly above prior year.
- Gross margin 71.0% vs 74.5% YoY due to customer acquisition costs and higher raw ingredient costs.
- Entered $100M accelerated share repurchase; quarterly dividend $1.64/share.
- Full-year 2022 guidance lowered: revenue $1.58B-$1.66B (prev. $1.78B-$1.84B); adjusted EPS $12.70-$14.10 (prev. $14.60-$16.05) due to inflation and consumer sentiment.

## SEC filing metadata
- accession: 0001628280-22-020596
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2022-08-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828022020596/0001628280-22-020596-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828022020596/med-20220803.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-020596
- JSON: https://secwatch.observer/filing/0001628280-22-020596.json
- Plain text: https://secwatch.observer/filing/0001628280-22-020596.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.